LL-37 vs Melanotan II
Updated July 27, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of LL-37 and Melanotan II (also searched as Melanotan II vs LL-37) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
LL-37 centers on healing, while Melanotan II leans toward skin. On indexed research, LL-37 is ahead (LL-37: 5 studies, Human evidence; Melanotan II: 5, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •LL-37 is strongest for healing; Melanotan II for skin.
- •Evidence: LL-37 Human evidence (5 studies) vs Melanotan II Human evidence (5).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
Human Cathelicidin | Antimicrobial Peptide
Synthetic Melanocortin Peptide | Tanning & Sexual Function
LL-37 vs Melanotan II: side-by-side
| Metric | LL-37 | Melanotan II |
|---|---|---|
| Class | Immune | Skin |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Human evidence | Human evidence |
| Studies indexed | 5 | 5 |
| Research level | Well Studied | Well Studied |
| Strongest effect | Healing & recovery | Skin & aesthetics |
| Healing & recovery | 4.0▲ | 0.0 |
| Muscle & body comp | 0.0 | 0.0 |
| Metabolic & appetite | 0.0 | 0.0 |
| Neuro & mood | 0.0 | 2.0▲ |
| Sleep & circadian | 0.0 | 0.0 |
| Inflammation & immune | 4.0▲ | 0.0 |
| Skin & aesthetics | 0.0 | 5.0▲ |
▲ marks the higher AI-assigned effect score (0–5, describing where the literature concentrates — not clinical efficacy).
Mechanism & pharmacokinetics
| Property | LL-37 | Melanotan II |
|---|---|---|
| Mechanism | Disrupts microbial membranes; modulates immune responses | Melanocortin-receptor agonist |
| Route | — | Subcutaneous injection (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is LL-37?
### LL-37 Summary LL-37 is a human cathelicidin antimicrobial peptide that plays a crucial role in the innate immune response, exhibiting antimicrobial, immunomodulatory, and wound healing properties. Its diverse functions make it a subject of interest in various fields of biomedical research.
Full LL-37 profile, mechanism & studies →What is Melanotan II?
### Summary Melanotan II is a synthetic analog of the naturally occurring peptide hormone alpha-melanocyte-stimulating hormone (α-MSH), primarily studied for its effects on skin pigmentation and potential therapeutic applications. Research has also explored its impact on mood and stress responses, though caution is advised due to potential side effects and safety concerns.
Full Melanotan II profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | LL-37 | 4.0/5 effect signal |
| Neuro | Melanotan II | 2.0/5 effect signal |
| Inflammation | LL-37 | 4.0/5 effect signal |
| Skin | Melanotan II | 5.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack LL-37 and Melanotan II?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
LL-37 vs Melanotan II: side effects
No community-reported effects logged yet.
No community-reported effects logged yet.
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
LL-37 has 5 approved studies indexed (Human evidence), and Melanotan II has 5 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is LL-37 or Melanotan II better?
It depends on your goal. LL-37 is strongest for healing; Melanotan II for skin. LL-37 has more indexed studies (5). See the goal-by-goal breakdown above.
Which has more research, LL-37 or Melanotan II?
LL-37 has 5 approved studies indexed (Human evidence); Melanotan II has 5 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack LL-37 and Melanotan II?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of LL-37 vs Melanotan II?
LL-37: no community-reported effects logged yet. Melanotan II: none logged yet. These are anonymous reports, not incidence rates — see each profile.
Is LL-37 or Melanotan II FDA-approved?
LL-37 is a research-use compound and is not FDA-approved. Melanotan II is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is Melanotan II better than LL-37?
For skin, Melanotan II has the edge; for healing, LL-37 does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
LL-37 and Melanotan II are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 27, 2026.